The report will be delivered in 2-3 business days.

Musculoskeletal Disorders Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery

Starting Price : $ 4000.00 $3200.00 | Pages : 150 | Published : May 2020 | SKU CODE : 8384 | Format :


The musculoskeletal disorders drugs market consists of sales of musculoskeletal disorders drugs and related services by entities (organizations, sole traders and partnerships) that produce musculoskeletal disorders drugs to treat musculoskeletal disorders such as arthritis, osteoporosis, osteomalacia, and other disorders. This industry includes establishments that produce drugs to treat rheumatoid arthritis, muscle relaxants to reduce muscle pain, and other drugs used in treating osteoarthritis, analgesics drugs, immunosuppressives.

The global musculoskeletal disorders drugs market is expected to decline from $85.7 billion in 2019 to $75.5 billion in 2020 at a compound annual growth rate (CAGR) of -12%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. COVID-19 pandemic is affecting industries across the globe including the pharmaceutical sector. The restrictions on non-essential medical services coupled with slowed production of drugs due to extended factory closures in various countries, shortage of APIs and other chemicals, and rise in prices of key ingredients are the key factors for this decline. The market is then expected to recover and grow at a CAGR of 4% from 2021 and reach $94.8 billion in 2023.

North America was the largest region in the global musculoskeletal disorders drugs market, accounting for 53% of the market in 2019. Asia Pacific was the second largest region accounting for 27% of the global musculoskeletal disorders drugs market. Africa was the smallest region in the global musculoskeletal disorders drugs market.

Introduction of advanced pain free drug delivery technologies is promoting the use of musculoskeletal drugs. Drug delivery systems refer to methods or processes used to administer a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Drug delivery products such as intrathecal pumps are being used to deliver muscle relaxants such as baclofen directly into spinal cord to provide instant relief. Intra-Articular drug delivery systems are also widely being used to administer medicines to treat arthritis.  In addition, these products reduce spasticity symptoms and lower the side effects caused by oral spasticity medications.

The major players in the global musculoskeletal disorders drugs market are F. Hoffmann-La Roche Ltd, GlaxosmithKline Plc, Pfizer Inc, Abbott Laboratories Inc, Daiichi Sankyo Company

The countries covered in the global musculoskeletal disorders drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

The Global Musculoskeletal Disorders Drugs Market is segmented: 1) By Type: Drugs For Rheumatoid Arthritis, Muscle Relaxants, Others - Musculoskeletal Disorders Drugs 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others 3) By Route Of Administration: Oral, Parenteral, Others 4) By Drug Classification: Branded Drugs, Generic Drugs 5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

    1. Executive Summary

    2. Report Structure

    3. Musculoskeletal Disorders Drugs Market Characteristics

    3.1. Market Definition

    3.2. Key Segmentations

    4. Musculoskeletal Disorders Drugs Market Product Analysis

    4.1. Leading Products/ Services

    4.2. Key Features and Differentiators

    4.3. Development Products

    5. Musculoskeletal Disorders Drugs Market Supply Chain

    5.1. Supply Chain

    5.2. Distribution

    5.3. End Customers

    6. Musculoskeletal Disorders Drugs Market Customer Information

    6.1. Customer Preferences

    6.2. End Use Market Size and Growth

    7. Musculoskeletal Disorders Drugs Market Trends And Strategies

    8. Musculoskeletal Disorders Drugs Market Size And Growth

    8.1. Market Size

    8.2. Historic Market Growth, Value ($ Billion)

    8.2.1. Drivers Of The Market

    8.2.2. Restraints On The Market

    8.3. Forecast Market Growth, Value ($ Billion)

    8.3.1. Drivers Of The Market

    8.3.2. Restraints On The Market

    9. Musculoskeletal Disorders Drugs Market Regional Analysis

    9.1. Global Musculoskeletal Disorders Drugs Market, 2019, By Region, Value ($ Billion)

    9.2. Global Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region

    9.3. Global Musculoskeletal Disorders Drugs Market, Growth And Market Share Comparison, By Region

    10. Musculoskeletal Disorders Drugs Market Segmentation

    10.1. Global Musculoskeletal Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Drugs For Rheumatoid Arthritis

    Muscle Relaxants

    Others - Musculoskeletal Disorders Drugs

    10.2. Global Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies/ Drug Stores

    Others

    10.3. Global Musculoskeletal Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Oral

    Parenteral

    Others

    10.4. Global Musculoskeletal Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Branded Drugs

    Generic Drugs

    10.5. Global Musculoskeletal Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Prescription-Based Drugs

    Over-The-Counter Drugs

    11. Musculoskeletal Disorders Drugs Market Metrics

    11.1. Musculoskeletal Disorders Drugs Market Size, Percentage Of GDP, 2015-2023, Global

    11.2. Per Capita Average Musculoskeletal Disorders Drugs Market Expenditure, 2015-2023, Global

    12. Asia-Pacific Musculoskeletal Disorders Drugs Market

    12.1. Asia-Pacific Musculoskeletal Disorders Drugs Market Overview

    12.2. Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)

    12.3. Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    12.4. Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    12.5. Asia-Pacific, Musculoskeletal Disorders Drugs Market Metrics

    12.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Asia-Pacific Countries

    12.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Asia-Pacific Countries

    12.6. Asia-Pacific Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7. Asia-Pacific Musculoskeletal Disorders Drugs Market: Country Analysis

    12.7.1. China Musculoskeletal Disorders Drugs Market

    12.7.1.1. China Musculoskeletal Disorders Drugs Market Overview

    12.7.1.2. China Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.1.3. China Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.2. Australia Musculoskeletal Disorders Drugs Market

    12.7.2.1. Australia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.2.2. Australia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.3. Hong Kong Musculoskeletal Disorders Drugs Market

    12.7.3.1. Hong Kong Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.4. India Musculoskeletal Disorders Drugs Market

    12.7.4.1. India Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.4.2. India Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.5. Indonesia Musculoskeletal Disorders Drugs Market

    12.7.5.1. Indonesia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.5.2. Indonesia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.6. Japan Musculoskeletal Disorders Drugs Market

    12.7.6.1. Japan Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.6.2. Japan Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.7. Malaysia Musculoskeletal Disorders Drugs Market

    12.7.7.1. Malaysia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.8. New Zealand Musculoskeletal Disorders Drugs Market

    12.7.8.1. New Zealand Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.9. Philippines Musculoskeletal Disorders Drugs Market

    12.7.9.1. Philippines Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.10. Singapore Musculoskeletal Disorders Drugs Market

    12.7.10.1. Singapore Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.11. South Korea Musculoskeletal Disorders Drugs Market

    12.7.11.1. South Korea Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.11.2. South Korea Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.12. Thailand Musculoskeletal Disorders Drugs Market

    12.7.12.1. Thailand Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.13. Vietnam Musculoskeletal Disorders Drugs Market

    12.7.13.1. Vietnam Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13. Western Europe Musculoskeletal Disorders Drugs Market

    13.1. Western Europe Musculoskeletal Disorders Drugs Market Overview

    13.2. Western Europe, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)

    13.3. Western Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    13.4. Western Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    13.5. Western Europe, Musculoskeletal Disorders Drugs Market Metrics

    13.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Western Europe Countries

    13.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Western Europe Countries

    13.6. Western Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7. Western Europe Musculoskeletal Disorders Drugs Market: Country Analysis

    13.7.1. Austria Musculoskeletal Disorders Drugs Market

    13.7.1.1. Austria Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.2. Belgium Musculoskeletal Disorders Drugs Market

    13.7.2.1. Belgium Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.3. Denmark Musculoskeletal Disorders Drugs Market

    13.7.3.1. Denmark Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.4. Finland Musculoskeletal Disorders Drugs Market

    13.7.4.1. Finland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.5. France Musculoskeletal Disorders Drugs Market

    13.7.5.1. France Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.5.2. France Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.6. Germany Musculoskeletal Disorders Drugs Market

    13.7.6.1. Germany Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.6.2. Germany Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.7. Ireland Musculoskeletal Disorders Drugs Market

    13.7.7.1. Ireland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.8. Italy Musculoskeletal Disorders Drugs Market

    13.7.8.1. Italy Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.9. Netherlands Musculoskeletal Disorders Drugs Market

    13.7.9.1. Netherlands Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.10. Norway Musculoskeletal Disorders Drugs Market

    13.7.10.1. Norway Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.11. Portugal Musculoskeletal Disorders Drugs Market

    13.7.11.1. Portugal Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.12. Spain Musculoskeletal Disorders Drugs Market

    13.7.12.1. Spain Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.13. Sweden Musculoskeletal Disorders Drugs Market

    13.7.13.1. Sweden Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.14. Switzerland Musculoskeletal Disorders Drugs Market

    13.7.14.1. Switzerland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.15. UK Musculoskeletal Disorders Drugs Market

    13.7.15.1. UK Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.15.2. UK Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14. Eastern Europe Musculoskeletal Disorders Drugs Market

    14.1. Eastern Europe Musculoskeletal Disorders Drugs Market Overview

    14.2. Eastern Europe, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)

    14.3. Eastern Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    14.4. Eastern Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    14.5. Eastern Europe, Musculoskeletal Disorders Drugs Market Metrics

    14.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Eastern Europe Countries

    14.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Eastern Europe Countries

    14.6. Eastern Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7. Eastern Europe Musculoskeletal Disorders Drugs Market: Country Analysis

    14.7.1. Czech Republic Musculoskeletal Disorders Drugs Market,  

    14.7.1.1. Czech Republic Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.2. Poland Musculoskeletal Disorders Drugs Market

    14.7.2.1. Poland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.3. Romania Musculoskeletal Disorders Drugs Market

    14.7.3.1. Romania Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.4. Russia Musculoskeletal Disorders Drugs Market

    14.7.4.1. Russia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.4.2. Russia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15. North America Musculoskeletal Disorders Drugs Market

    15.1. North America Musculoskeletal Disorders Drugs Market Overview

    15.2. North America, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)

    15.3. North America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    15.4. North America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    15.5. North America, Musculoskeletal Disorders Drugs Market Metrics

    15.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, North America Countries

    15.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, North America Countries

    15.6. North America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7. North America Musculoskeletal Disorders Drugs Market: Country Analysis

    15.7.1. Canada Musculoskeletal Disorders Drugs Market

    15.7.1.1. Canada Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7.2. Mexico Musculoskeletal Disorders Drugs Market

    15.7.2.1. Mexico Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7.3. USA Musculoskeletal Disorders Drugs Market

    15.7.3.1. USA Musculoskeletal Disorders Drugs Market Overview

    15.7.3.2. USA Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7.3.3. USA Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16. South America Musculoskeletal Disorders Drugs Market

    16.1. South America Musculoskeletal Disorders Drugs Market Overview

    16.2. South America, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)

    16.3. South America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    16.4. South America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    16.5. South America, Musculoskeletal Disorders Drugs Market Metrics

    16.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, South America Countries

    16.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, South America Countries

    16.6. South America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7. South America Musculoskeletal Disorders Drugs Market: Country Analysis

    16.7.1. Argentina Musculoskeletal Disorders Drugs Market

    16.7.1.1. Argentina Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.2. Brazil Musculoskeletal Disorders Drugs Market

    16.7.1.1. Brazil Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.2.2. Brazil Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.3. Chile Musculoskeletal Disorders Drugs Market

    16.7.3.1. Chile Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.4. Colombia Musculoskeletal Disorders Drugs Market

    16.7.4.1. Colombia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.5. Peru Musculoskeletal Disorders Drugs Market

    16.7.5.1. Peru Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.6. Venezuela Musculoskeletal Disorders Drugs Market

    16.7.6.1. Venezuela Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17. Middle East Musculoskeletal Disorders Drugs Market

    17.1. Middle East Musculoskeletal Disorders Drugs Market Overview

    17.2. Middle East, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)

    17.3. Middle East, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    17.4. Middle East, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    17.5. Middle East, Musculoskeletal Disorders Drugs Market Metrics

    17.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Middle East Countries

    17.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Middle East Countries

    17.6. Middle East Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7. Middle East Musculoskeletal Disorders Drugs Market: Country Analysis

    17.7.1. Saudi Arabia Musculoskeletal Disorders Drugs Market

    17.7.1.1. Saudi Arabia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7.2. Israel Musculoskeletal Disorders Drugs Market

    17.7.2.1. Israel Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7.3. Turkey Musculoskeletal Disorders Drugs Market

    17.7.3.1. Turkey Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7.4. UAE Musculoskeletal Disorders Drugs Market

    17.7.4.1. UAE Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18. Africa Musculoskeletal Disorders Drugs Market

    18.1. Africa Musculoskeletal Disorders Drugs Market Overview

    18.2. Africa, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)

    18.3. Africa, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    18.4. Africa, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    18.5. Africa, Musculoskeletal Disorders Drugs Market Metrics

    18.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Africa Countries

    18.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Africa Countries

    18.6. Africa Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18.7. Africa Musculoskeletal Disorders Drugs Market: Country Analysis

    18.7.1. Egypt Musculoskeletal Disorders Drugs Market

    18.7.1.1. Egypt Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18.7.2. Nigeria Musculoskeletal Disorders Drugs Market

    18.7.2.1. Nigeria Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18.7.3. South Africa Musculoskeletal Disorders Drugs Market

    18.7.3.1. South Africa Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    19. Musculoskeletal Disorders Drugs Market Competitive Landscape

    19.1. Competitive Market Overview

    19.2. Market Shares

    19.3. Company Profiles

    19.3.1. F. Hoffmann-La Roche Ltd

    19.3.1.1. Company Overview

    19.3.1.2. Products And Services

    19.3.1.3. Strategy

    19.3.1.4. Financial Performance

    19.3.2. GlaxosmithKline Plc

    19.3.2.1. Company Overview

    19.3.2.2. Products And Services

    19.3.2.3. Strategy

    19.3.2.4. Financial Performance

    19.3.3. Pfizer Inc

    19.3.3.1. Company Overview

    19.3.3.2. Products And Services

    19.3.3.3. Strategy

    19.3.3.4. Financial Performance

    19.3.4. Abbott Laboratories Inc

    19.3.4.1. Company Overview

    19.3.4.2. Products And Services

    19.3.4.3. Strategy

    19.3.4.4. Financial Performance

    19.3.5. Daiichi Sankyo Company

    19.3.5.1. Company Overview

    19.3.5.2. Products And Services

    19.3.5.3. Strategy

    19.3.5.4. Financial Performance

    20. Key Mergers And Acquisitions In The Musculoskeletal Disorders Drugs Market

    21. Market Background: Pharmaceutical Drugs Market

    21.1. Pharmaceutical Drugs Market Characteristics

    21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global

    21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)

    21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region

    21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

    22. Recommendations

    22.1. Global Musculoskeletal Disorders Drugs Market In 2023- Growth Countries

    22.2. Global Musculoskeletal Disorders Drugs Market In 2023- Growth Segments

    22.3. Global Musculoskeletal Disorders Drugs Market In 2023- Growth Strategies

    23. Appendix

    23.1. NAICS Definitions Of Industry Covered In This Report

    23.2. Abbreviations

    23.3. Currencies

    23.4. Research Inquiries

    23.5. The Business Research Company

    24. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Musculoskeletal Disorders Drugs Market, 2019, By Region, Value ($ Billion)
  • Table 4: Global Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Table 5: Global Musculoskeletal Disorders Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Musculoskeletal Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Global Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: Global Musculoskeletal Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: Global Musculoskeletal Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: Global Musculoskeletal Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: Musculoskeletal Disorders Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • Table 12: Per Capita Average Musculoskeletal Disorders Drugs Market Expenditure, 2015-2023, Global
  • Table 13: Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 14: Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 15: Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 16: Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Asia-Pacific Countries
  • Table 17: Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Asia-Pacific Countries
  • Table 18: Asia-Pacific Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 19: China Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 20: China Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 21: Australia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 22: Australia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 23: Hong Kong Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 24: India Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 25: India Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 26: Indonesia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 27: Indonesia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 28: Japan Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 29: Japan Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 30: Malaysia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 31: New Zealand Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 32: Philippines Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 33: Singapore Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 34: South Korea Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 35: Thailand Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 36: Vietnam Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 37: Western Europe, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 38: Western Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 39: Western Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 40: Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Western Europe Countries
  • Table 41: Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Western Europe Countries
  • Table 42: Western Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 43: Austria Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 44: Belgium Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 45: Denmark Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 46: Finland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 47: France Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 48: France Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 49: Germany Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 50: Germany Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 51: Ireland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 52: Italy Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 53: Netherlands Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 54: Norway Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 55: Portugal Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 56: Spain Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 57: Sweden Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 58: Switzerland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 59: UK Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 60: UK Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 61: Eastern Europe, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 62: Eastern Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 63: Eastern Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 64: Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Eastern Europe Countries
  • Table 65: Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Eastern Europe Countries
  • Table 66: Eastern Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 67: Czech Republic Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 68: Poland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 69: Romania Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 70: Russia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 71: Russia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 72: North America, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 73: North America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 74: North America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 75: Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, North America Countries
  • Table 76: Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, North America Countries
  • Table 77: North America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 78: Canada Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 79: Mexico Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 80: USA Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 81: USA Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 82: South America, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 83: South America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 84: South America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 85: Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, South America Countries
  • Table 86: Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, South America Countries
  • Table 87: South America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 88: Argentina Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 89: Brazil Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 90: Brazil Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 91: Chile Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 92: Colombia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 93: Peru Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 94: Venezuela Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 95: Middle East, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 96: Middle East, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 97: Middle East, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 98: Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Middle East Countries
  • Table 99: Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Middle East Countries
  • Table 100: Middle East Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 101: Saudi Arabia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 102: Israel Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 103: Turkey Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 104: UAE Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 105: Africa, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 106: Africa, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 107: Africa, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 108: Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Africa Countries
  • Table 109: Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Africa Countries
  • Table 110: Africa Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 111: Egypt Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 112: Nigeria Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 113: South Africa Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 114: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 115: GlaxosmithKline Plc Financial Performance
  • Table 116: Pfizer Inc Financial Performance
  • Table 117: Abbott Laboratories Inc Financial Performance
  • Table 118: Daiichi Sankyo Company Financial Performance
  • Table 119: Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Table 120: Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • Table 121: Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Table 122: Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Table 123: Global Musculoskeletal Disorders Drugs Market In 2023- Growth Countries
  • Table 124: Global Musculoskeletal Disorders Drugs Market In 2023- Growth Segments
  • Table 125: Global Musculoskeletal Disorders Drugs Market In 2023- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Musculoskeletal Disorders Drugs Market, 2019, By Region, Value ($ Billion)
  • Figure 4: Global Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Figure 5: Global Musculoskeletal Disorders Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Musculoskeletal Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: Global Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: Global Musculoskeletal Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: Global Musculoskeletal Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: Global Musculoskeletal Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: Musculoskeletal Disorders Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • Figure 12: Per Capita Average Musculoskeletal Disorders Drugs Market Expenditure, 2015-2023, Global
  • Figure 13: Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 14: Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 15: Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 16: Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Asia-Pacific Countries
  • Figure 17: Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Asia-Pacific Countries
  • Figure 18: Asia-Pacific Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 19: China Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 20: China Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 21: Australia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 22: Australia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 23: Hong Kong Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 24: India Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 25: India Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 26: Indonesia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 27: Indonesia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 28: Japan Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 29: Japan Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 30: Malaysia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 31: New Zealand Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 32: Philippines Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 33: Singapore Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 34: South Korea Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 35: Thailand Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 36: Vietnam Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 37: Western Europe, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 38: Western Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 39: Western Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 40: Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Western Europe Countries
  • Figure 41: Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Western Europe Countries
  • Figure 42: Western Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 43: Austria Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 44: Belgium Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 45: Denmark Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 46: Finland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 47: France Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 48: France Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 49: Germany Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 50: Germany Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 51: Ireland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 52: Italy Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 53: Netherlands Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 54: Norway Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 55: Portugal Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 56: Spain Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 57: Sweden Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 58: Switzerland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 59: UK Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 60: UK Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 61: Eastern Europe, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 62: Eastern Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 63: Eastern Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 64: Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Eastern Europe Countries
  • Figure 65: Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Eastern Europe Countries
  • Figure 66: Eastern Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 67: Czech Republic Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 68: Poland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 69: Romania Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 70: Russia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 71: Russia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 72: North America, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 73: North America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 74: North America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 75: Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, North America Countries
  • Figure 76: Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, North America Countries
  • Figure 77: North America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 78: Canada Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 79: Mexico Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 80: USA Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 81: USA Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 82: South America, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 83: South America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 84: South America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 85: Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, South America Countries
  • Figure 86: Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, South America Countries
  • Figure 87: South America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 88: Argentina Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 89: Brazil Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 90: Brazil Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 91: Chile Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 92: Colombia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 93: Peru Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 94: Venezuela Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 95: Middle East, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 96: Middle East, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 97: Middle East, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 98: Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Middle East Countries
  • Figure 99: Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Middle East Countries
  • Figure 100: Middle East Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 101: Saudi Arabia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 102: Israel Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 103: Turkey Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 104: UAE Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 105: Africa, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 106: Africa, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 107: Africa, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 108: Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Africa Countries
  • Figure 109: Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Africa Countries
  • Figure 110: Africa Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 111: Egypt Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 112: Nigeria Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 113: South Africa Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 114: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 115: GlaxosmithKline Plc Financial Performance
  • Figure 116: Pfizer Inc Financial Performance
  • Figure 117: Abbott Laboratories Inc Financial Performance
  • Figure 118: Daiichi Sankyo Company Financial Performance
  • Figure 119: Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Figure 120: Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • Figure 121: Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Figure 122: Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Figure 123: Global Musculoskeletal Disorders Drugs Market In 2023- Growth Countries
  • Figure 124: Global Musculoskeletal Disorders Drugs Market In 2023- Growth Segments
  • Figure 125: Global Musculoskeletal Disorders Drugs Market In 2023- Growth Strategies
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)